Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ADMA

ADMA Biologics, Inc.

Healthcare · USD

Set alert

Price alert · ADMA

All alert types
11.41 USD -0.34 -2.89%
As of Oct 30, 2026 Extended hours 11.25 -1.40%
Bid
11.42 × 2
Ask
11.43 × 2
11.37 Day range 11.90
7.60 52-week range 20.38
YTD
-37.45%
1 year
-25.28%
Open
11.85
Prev close
11.75
Mkt cap
2.56B
Vol
2.46M
Avg vol
2.68M
EPS
0.70
P/E
16.30
Div yield
0.00%
More statistics
Low
11.37
High
11.90
Forward P/E
12.07
Beta
0.69
Short ratio
5.82
Inst. own
92.51%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
9.97
200-d avg
10.99
1y target
17.00

5D chart

Chart tools
Interval
1m5m15m30m
ADMA five-day price chart10.711.011.311.611.9Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

8.19 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 2
  • P/E 3
  • P/B 2

Valuation

P/E 29.4×
FY 2016: -3.2×FY 2017: -1.7×FY 2018: -1.6×FY 2019: -3.8×FY 2020: -1.9×FY 2021: -2.3×FY 2022: -9.0×FY 2023: -34.8×FY 2024: 20.2×FY 2025: 29.4×
FY 2016 5y median -2.3× FY 2025
P/S 8.5×
FY 2016: 5.8×FY 2017: 3.2×FY 2018: 6.4×FY 2019: 7.4×FY 2020: 4.0×FY 2021: 2.4×FY 2022: 5.0×FY 2023: 3.9×FY 2024: 9.4×FY 2025: 8.5×
FY 2016 5y median 5.0× FY 2025
P/B 9.1×
FY 2016: -14.0×FY 2017: 1.8×FY 2018: 5.5×FY 2019: 8.3×FY 2020: 1.9×FY 2021: 1.4×FY 2022: 5.1×FY 2023: 7.5×FY 2024: 11.5×FY 2025: 9.1×
FY 2016 5y median 7.5× FY 2025
P/FCF 156×
FY 2016: -3.4×FY 2017: -1.8×FY 2018: -1.7×FY 2019: -2.7×FY 2020: -1.5×FY 2021: -1.6×FY 2022: -10.5×FY 2023: 265×FY 2024: 36.3×FY 2025: 156×
FY 2016 5y median 36.3× FY 2025
EV/EBITDA 21.9×
FY 2016: -4.3×FY 2017: -1.9×FY 2018: -2.3×FY 2019: -7.6×FY 2020: -3.5×FY 2021: -4.7×FY 2022: -21.2×FY 2023: 215×FY 2024: 26.9×FY 2025: 21.9×
FY 2016 5y median 21.9× FY 2025
EV/Sales 8.5×
FY 2016: 6.8×FY 2017: 3.2×FY 2018: 7.6×FY 2019: 9.4×FY 2020: 5.0×FY 2021: 3.1×FY 2022: 5.4×FY 2023: 4.3×FY 2024: 9.3×FY 2025: 8.5×
FY 2016 5y median 5.4× FY 2025
FCF Yield 0.6%
FY 2016: -29.5%FY 2017: -54.4%FY 2018: -60.0%FY 2019: -36.8%FY 2020: -68.3%FY 2021: -64.0%FY 2022: -9.6%FY 2023: 0.4%FY 2024: 2.8%FY 2025: 0.6%
FY 2016 5y median 0.4% FY 2025

Profitability

Gross Margin 57.4%
FY 2016: 40.3%FY 2017: -28.1%FY 2018: -148.4%FY 2019: -34.6%FY 2020: -45.2%FY 2021: 1.4%FY 2022: 22.9%FY 2023: 34.4%FY 2024: 51.5%FY 2025: 57.4%
FY 2016 5y median 34.4% FY 2025
Operating Margin 37.5%
FY 2016: -162.6%FY 2017: -172.7%FY 2018: -354.9%FY 2019: -141.1%FY 2020: -153.8%FY 2021: -72.1%FY 2022: -25.5%FY 2023: 8.4%FY 2024: 32.6%FY 2025: 37.5%
FY 2016 5y median 8.4% FY 2025
Net Margin 28.8%
FY 2016: -183.1%FY 2017: -192.3%FY 2018: -387.1%FY 2019: -164.5%FY 2020: -179.4%FY 2021: -88.5%FY 2022: -42.8%FY 2023: -10.9%FY 2024: 46.4%FY 2025: 28.8%
FY 2016 5y median -10.9% FY 2025
ROE 30.8%
FY 2016: 437.8%FY 2017: -108.5%FY 2018: -332.5%FY 2019: -184.3%FY 2020: -85.8%FY 2021: -50.8%FY 2022: -43.4%FY 2023: -20.9%FY 2024: 56.6%FY 2025: 30.8%
FY 2016 5y median -20.9% FY 2025
ROIC 27.6%
FY 2016: -93.2%FY 2017: -39.9%FY 2018: -76.0%FY 2019: -36.6%FY 2020: -34.5%FY 2021: -23.7%FY 2022: -12.7%FY 2023: 7.7%FY 2024: 32.0%FY 2025: 27.6%
FY 2016 5y median 7.7% FY 2025
ROA 23.5%
FY 2016: -82.4%FY 2017: -40.5%FY 2018: -74.0%FY 2019: -38.0%FY 2020: -36.5%FY 2021: -25.9%FY 2022: -18.9%FY 2023: -8.6%FY 2024: 40.5%FY 2025: 23.5%
FY 2016 5y median -8.6% FY 2025

Growth (YoY)

Revenue 19.6%
FY 2016: 48.5%FY 2017: 113.5%FY 2018: -25.4%FY 2019: 72.8%FY 2020: 43.9%FY 2021: 91.7%FY 2022: 90.4%FY 2023: 67.6%FY 2024: 65.2%FY 2025: 19.6%
FY 2016 FY 2025
Operating Income 37.7%
FY 2016: -11.7%FY 2017: -126.8%FY 2018: -53.4%FY 2019: 31.3%FY 2020: -56.7%FY 2021: 10.1%FY 2022: 32.6%FY 2023: 155.0%FY 2024: 542.5%FY 2025: 37.7%
FY 2016 FY 2025
EPS (diluted) -25.9%
FY 2016: 6.9%FY 2017: -18.6%FY 2018: 24.1%FY 2019: 27.6%FY 2020: 2.9%FY 2021: 40.2%FY 2022: 29.5%FY 2023: 69.8%FY 2024: 723.1%FY 2025: -25.9%
FY 2016 FY 2025
Free Cash Flow -74.7%
FY 2016: -18.8%FY 2017: -117.8%FY 2018: -62.1%FY 2019: -23.5%FY 2020: -43.4%FY 2021: -9.7%FY 2022: 41.7%FY 2023: 105.2%FY 2024: 2782.9%FY 2025: -74.7%
FY 2016 FY 2025

Financial Health

Current Ratio 6.7×
FY 2016: 1.9×FY 2017: 6.7×FY 2018: 4.6×FY 2019: 6.1×FY 2020: 7.7×FY 2021: 6.9×FY 2022: 6.9×FY 2023: 5.2×FY 2024: 6.0×FY 2025: 6.7×
FY 2016 5y median 6.7× FY 2025
Quick Ratio 3.7×
FY 2016: 1.5×FY 2017: 5.4×FY 2018: 2.7×FY 2019: 2.3×FY 2020: 3.6×FY 2021: 2.8×FY 2022: 2.7×FY 2023: 1.7×FY 2024: 2.9×FY 2025: 3.7×
FY 2016 5y median 2.8× FY 2025
Debt / Equity 0.2×
FY 2016: -4.5×FY 2017: 1.1×FY 2018: 2.2×FY 2019: 3.2×FY 2020: 1.1×FY 2021: 0.7×FY 2022: 1.0×FY 2023: 1.0×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA -0.0×
FY 2016: -0.6×FY 2017: 0.0×FY 2018: -0.4×FY 2019: -1.6×FY 2020: -0.7×FY 2021: -1.0×FY 2022: -1.7×FY 2023: 17.6×FY 2024: -0.1×FY 2025: -0.0×
FY 2016 5y median -0.1× FY 2025
Interest Coverage 26.9×
FY 2016: -7.7×FY 2017: -12.0×FY 2018: -10.9×FY 2019: -4.6×FY 2020: -5.4×FY 2021: -4.5×FY 2022: -2.0×FY 2023: 0.9×FY 2024: 10.0×FY 2025: 26.9×
FY 2016 5y median 0.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31